⏳ Fetching live dividend data...
Home › Calculator › GIFOF Dividend Calculator 2026
Grifols, S.A. · OTC
Price: $8.85 · Annual div: $0.18/share · Frequency: quarterly · Payout ratio: 50% · Ex-div: TBD
Click to apply scenario to the calculator
Year your monthly dividend income covers each expense (based on current settings)
$10,000 in GIFOF → $315.7K in 10 years · $59.08/month
Grifols, S.A. is a Barcelona, Spain-based pharmaceutical company founded in 1940. The company primarily specializes in the acquisition, production, and distribution of therapeutic solutions, with a significant emphasis on products derived from human plasma. Its operations are divided into several key business units: The Bioscience division is dedicated to the research, development, manufacturing, and commercialization of plasma-based medicines and other cutting-edge therapies. These are designed to treat patients suffering from chronic, rare, prevalent, and life-threatening conditions. Their product portfolio includes immunoglobulins, alpha-1 antitrypsin, albumin, clotting factors, and hyperimmune globulins. The Hospital division supplies non-biological pharmaceutical items, medical consumables, clinical nutrition products, intravenous treatments, and various medical devices to healthcare facilities. The Diagnostic division focuses on innovating, producing, and bringing to market diagnostic tools. These tools support the entire healthcare process, from disease prevention and initial screening to definitive diagnosis, prognosis, and ongoing treatment monitoring for medical professionals. The Bio Supplies division provides essential biological materials used in life-science research, clinical trials, and the manufacturing of pharmaceutical and diagnostic goods. Grifols' diverse range of products and services are utilized by healthcare providers worldwide for diagnosing and treating a variety of medical conditions, including hemophilia, immune system disorders, and infectious diseases. The company caters to a wide customer base that includes both public and private sector clients, wholesalers, distributors, group purchasing organizations, blood banks, hospitals, care institutions, and national health systems. Furthermore, Grifols, S.A. maintains a technological collaboration agreement with Mondragon.
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. · Privacy Policy
Ready to invest? Open GIFOF position with:
Real after-tax yield depends on where you live and how you hold GIFOF.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| 🇺🇸 Roth IRA / 401k | 0% | 2.03% | -0.77% | $203 / yr |
| 🇺🇸 US Taxable (15%) ✓ | 15% | 1.73% | -1.07% | $173 / yr |
| 🇺🇸 US Taxable (20%) | 20% | 1.62% | -1.18% | $162 / yr |
| 🇬🇧 UK ISA | 0% | 2.03% | -0.77% | $203 / yr |
| 🇬🇧 UK Taxable | 8.75% | 1.85% | -0.95% | $185 / yr |
| 🇨🇦 TFSA | 0% | 2.03% | -0.77% | $203 / yr |
| 🇨🇦 CA Taxable | 25% | 1.52% | -1.28% | $152 / yr |
| 🇦🇺 Super (pension) | 15% | 1.73% | -1.07% | $173 / yr |
| 🇦🇺 AU Taxable | 30% | 1.42% | -1.38% | $142 / yr |
| 🇩🇪 DE Taxable | 26.375% | 1.49% | -1.31% | $149 / yr |
| 🇫🇷 FR Taxable | 30% | 1.42% | -1.38% | $142 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
12-month CPI (US BLS via FMP economic-indicators).
Based on current dividend of $0.18/share/yr · 🇺🇸 US Taxable (15%) · static projection (no growth assumed).
GIFOF pays quarterly — 4 times per year. Next ex-div: TBD.
How GIFOF compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024–2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for GIFOF sourced from FMP /financial-growth endpoint — real data, not estimates.
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores → lower dividend cut risk. Data via FMP financial statements.
Revenue breakdown from latest annual report via FMP. Percentages may not sum to 100% due to rounding.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the GIFOF dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer →
Real users. No sign-up required to leave a review.
“Finally a free dividend calculator that doesn't make me sign up or connect my brokerage. Entered SCHD and got the full DRIP projection in seconds. Bookmarked immediately.”
“I've been trying to figure out how much dividend income I'd need to retire. This tool showed me exactly — $400K in JEPI at 7% yield gives me $2,333/month. No calculator did that this clearly before.”
“Really solid passive income calculator. Covers everything: DRIP compounding, Roth IRA tax savings, DCA contributions. The year-by-year breakdown is what I was missing from other tools.”
“As someone planning retirement in 5 years, this dividend yield calculator showed me I need about 12% more in dividend stocks to hit my income target. Incredibly useful and completely free.”
“The Congress trades tracker is genius. Saw that several senators were buying O (Realty Income) and immediately ran it through the DRIP calculator. Bought 50 shares the next day.”
Reviews reflect users' personal experiences. Not financial advice.
Leave a review →